Market Access Views & Analysis

Views & Analysis

Coronavirus pharma news roundup - 26/06/20

As COVID-19 drugs vie for approval, we highlight the top pharma R&D, digital and market access news for coronavirus from the past week.

Views & Analysis

Coronavirus pharma news roundup – 19/06/20

We highlight the top coronavirus news stories in pharma R&D, digital and market access news from the past week.

Views & Analysis

Healthcare’s ‘2008 banking moment’: What has COVID taught us...

COVID-19 has changed many elements of healthcare – from mental health to social care, from vaccines to virtual clinics.

Views & Analysis

Breaking barriers to patient access in rare oncology

As technological advances unlock a more nuanced understanding of disease – and exciting opportunities for personalised medicine – some cancers are now being redefined as rare diseases.

Views & Analysis

Getting the most out of technical engagement with NICE

In 2017 the UK’s National Institute for Health and Care Excellence (NICE)

Views & Analysis

Talking vaccines: Industry’s role in protecting the Gavi gen...

A new report highlights the important work of companies across the industry in boosting access to vaccines worldwide – and warns of the challenges ahead.

Coronavirus pharma news roundup - 26/06/20

Coronavirus pharma news roundup – 19/06/20

Healthcare’s ‘2008 banking moment’: What has COVID taught us...

Breaking barriers to patient access in rare oncology

Getting the most out of technical engagement with NICE

Talking vaccines: Industry’s role in protecting the Gavi gen...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks